Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells.

Wu HW, Sheard MA, Malvar J, Fernandez GE, DeClerck YA, Blavier L, Shimada H, Theuer CP, Sposto R, Seeger RC.

Clin Cancer Res. 2019 May 8. doi: 10.1158/1078-0432.CCR-18-3358. [Epub ahead of print]

PMID:
31068371
2.

Mental stress causes vasoconstriction in sickle cell disease and normal controls.

Shah P, Khaleel M, Thuptimdang W, Sunwoo J, Veluswamy S, Chalacheva P, Kato RM, Detterich J, Wood JC, Zeltzer L, Sposto R, Khoo MCK, Coates TD.

Haematologica. 2019 Apr 11. pii: haematol.2018.211391. doi: 10.3324/haematol.2018.211391. [Epub ahead of print]

3.

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Quereshi A, Cabannes A, Schlegel P, Rossig C, Dalla-Pozza L, August K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SR.

Leukemia. 2019 Apr;33(4):1061-1062. doi: 10.1038/s41375-019-0426-8.

PMID:
30842605
4.

Factors Leading to Decreased Rates of Immediate Postmastectomy Reconstruction.

Tung L, Jeong YJ, Lane C, Carey JN, Sposto R, Schechter NR, Sener SF, Lang JE.

J Surg Res. 2019 Jun;238:207-217. doi: 10.1016/j.jss.2019.01.010. Epub 2019 Feb 14.

PMID:
30772679
5.

Clinical findings and outcomes of MRI staging of breast cancer in a diverse population.

Raghavendra A, Wecsler J, Ji L, Sheth P, Ricker C, Church T, Sposto R, Lang J, Sener S, Larsen L, Tripathy D.

Breast Cancer Res Treat. 2019 Apr;174(2):315-324. doi: 10.1007/s10549-018-05084-w. Epub 2018 Dec 12. Review.

PMID:
30542816
6.

Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.

Kubala MH, Punj V, Placencio-Hickok VR, Fang H, Fernandez GE, Sposto R, DeClerck YA.

Cell Rep. 2018 Nov 20;25(8):2177-2191.e7. doi: 10.1016/j.celrep.2018.10.082.

7.

Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.

Osorio DS, Patel N, Ji L, Sposto R, Stanek J, Gardner SL, Allen JC, Cornelius A, McCowage GB, Termuhlen A, Dunkel IJ, Comito M, Garvin J, Finlay JL.

J Neurooncol. 2018 Dec;140(3):717-725. doi: 10.1007/s11060-018-03003-z. Epub 2018 Nov 3.

PMID:
30392092
8.

A novel cross-correlation methodology for assessing biophysical responses associated with pain.

Sunwoo J, Chalacheva P, Khaleel M, Shah P, Sposto R, Kato RM, Detterich J, Zeltzer LK, Wood JC, Coates TD, Khoo MC.

J Pain Res. 2018 Oct 5;11:2207-2219. doi: 10.2147/JPR.S142582. eCollection 2018.

9.

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Quereshi A, Cabannes A, Schlegel P, Rossig C, Dalla-Pozza L, August K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SR.

Leukemia. 2019 Apr;33(4):884-892. doi: 10.1038/s41375-018-0265-z. Epub 2018 Sep 28. Erratum in: Leukemia. 2019 Mar 7;:.

10.

Predictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer.

Brunette LL, Bonyadlou S, Ji L, Groshen S, Shuster D, Mehta A, Sposto R, Matsuo K, Lin YG, Roman LD.

Clin Nucl Med. 2018 Nov;43(11):793-801. doi: 10.1097/RLU.0000000000002252.

PMID:
30153151
11.

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study.

Sun W, Malvar J, Sposto R, Verma A, Wilkes JJ, Dennis R, Heym K, Laetsch TW, Widener M, Rheingold SR, Oesterheld J, Hijiya N, Sulis ML, Huynh V, Place AE, Bittencourt H, Hutchinson R, Messinger Y, Chang B, Matloub Y, Ziegler DS, Gardner R, Cooper T, Ceppi F, Hermiston M, Dalla-Pozza L, Schultz KR, Gaynon P, Wayne AS, Whitlock JA.

Leukemia. 2018 Nov;32(11):2316-2325. doi: 10.1038/s41375-018-0094-0. Epub 2018 Mar 15.

12.

Dose Sculpting Intensity Modulated Radiation Therapy for Vertebral Body Sparing in Children With Neuroblastoma.

Ng LW, Wong KK, Ally Wu CL, Sposto R, Olch AJ.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):550-557. doi: 10.1016/j.ijrobp.2018.02.015. Epub 2018 Feb 15.

PMID:
29680256
13.

Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes.

Webb MW, Sun J, Sheard MA, Liu WY, Wu HW, Jackson JR, Malvar J, Sposto R, Daniel D, Seeger RC.

Int J Cancer. 2018 Sep 15;143(6):1483-1493. doi: 10.1002/ijc.31532. Epub 2018 May 7.

PMID:
29665011
14.

Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis.

Maruffi M, Sposto R, Oberley MJ, Kysh L, Orgel E.

Leukemia. 2018 Jul;32(7):1515-1528. doi: 10.1038/s41375-018-0058-4. Epub 2018 Feb 27.

PMID:
29550836
15.

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Robison NJ, Yeo KK, Berliner AP, Malvar J, Sheard MA, Margol AS, Seeger RC, Rushing T, Finlay JL, Sposto R, Dhall G.

J Neurooncol. 2018 May;138(1):199-207. doi: 10.1007/s11060-018-2791-y. Epub 2018 Feb 9.

16.

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK.

Pediatr Blood Cancer. 2018 May;65(5):e26940. doi: 10.1002/pbc.26940. Epub 2018 Jan 19.

PMID:
29350464
17.

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium.

Sun W, Triche T Jr, Malvar J, Gaynon P, Sposto R, Yang X, Bittencourt H, Place AE, Messinger Y, Fraser C, Dalla-Pozza L, Salhia B, Jones P, Wayne AS, Gore L, Cooper TM, Liang G.

Blood. 2018 Mar 8;131(10):1145-1148. doi: 10.1182/blood-2017-09-803809. Epub 2018 Jan 16. No abstract available.

18.

Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC.

Hadjidaniel MD, Muthugounder S, Hung LT, Sheard MA, Shirinbak S, Chan RY, Nakata R, Borriello L, Malvar J, Kennedy RJ, Iwakura H, Akamizu T, Sposto R, Shimada H, DeClerck YA, Asgharzadeh S.

Oncotarget. 2017 Sep 16;8(53):91516-91529. doi: 10.18632/oncotarget.21066. eCollection 2017 Oct 31.

19.

A multi-institutional registry of pediatric hospital-acquired thrombosis cases: The Children's Hospital-Acquired Thrombosis (CHAT) project.

Jaffray J, Mahajerin A, Young G, Goldenberg N, Ji L, Sposto R, Stillings A, Krava E, Branchford B.

Thromb Res. 2018 Jan;161:67-72. doi: 10.1016/j.thromres.2017.11.019. Epub 2017 Dec 1.

PMID:
29207321
20.

Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting.

Wayne AS, Shin-Kashiyama E, Sposto R, Gaynon P.

Pediatr Hematol Oncol. 2017 Sep - Oct;34(6-7):349-354. doi: 10.1080/08880018.2017.1377329. Epub 2017 Nov 9.

21.

Inflammatory Breast Cancer Outcomes in a Contemporary Series.

Pan E, Tung L, Ragab O, Morocco E, Wecsler J, Sposto R, Raghavendra A, Chung E, Lang JE.

Anticancer Res. 2017 Sep;37(9):5057-5063.

PMID:
28870934
22.

Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.

Guerra JA, Dhall G, Marachelian A, Castillo E, Malvar J, Wong K, Sposto R, Finlay JL.

Bone Marrow Transplant. 2017 Nov;52(11):1543-1548. doi: 10.1038/bmt.2017.166. Epub 2017 Aug 7.

PMID:
28783147
23.

Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Khaleel M, Puliyel M, Shah P, Sunwoo J, Kato RM, Chalacheva P, Thuptimdang W, Detterich J, Wood JC, Tsao J, Zeltzer L, Sposto R, Khoo MCK, Coates TD.

Am J Hematol. 2017 Nov;92(11):1137-1145. doi: 10.1002/ajh.24858. Epub 2017 Aug 17.

24.

Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.

Borriello L, Nakata R, Sheard MA, Fernandez GE, Sposto R, Malvar J, Blavier L, Shimada H, Asgharzadeh S, Seeger RC, DeClerck YA.

Cancer Res. 2017 Sep 15;77(18):5142-5157. doi: 10.1158/0008-5472.CAN-16-2586. Epub 2017 Jul 7.

25.

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.

Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss BD, Goldsmith K, Granger M, Matthay KK, Groshen S, Asgharzadeh S, Sposto R, Seeger RC.

Clin Cancer Res. 2017 Sep 15;23(18):5374-5383. doi: 10.1158/1078-0432.CCR-16-2647. Epub 2017 May 30.

26.

Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease.

Chalacheva P, Khaleel M, Sunwoo J, Shah P, Detterich JA, Kato RM, Thuptimdang W, Meiselman HJ, Sposto R, Tsao J, Wood JC, Zeltzer L, Coates TD, Khoo MCK.

PLoS One. 2017 May 24;12(5):e0178353. doi: 10.1371/journal.pone.0178353. eCollection 2017.

27.

Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium Study.

Soni S, Abdel-Azim H, McManus M, Nemecek E, Sposto R, Woolfrey A, Frangoul H.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1134-1141. doi: 10.1016/j.bbmt.2017.03.037. Epub 2017 Apr 7.

28.

A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia.

Orgel E, Mueske NM, Sposto R, Gilsanz V, Wren TAL, Freyer DR, Butturini AM, Mittelman SD.

Leuk Lymphoma. 2017 Oct;58(10):2370-2378. doi: 10.1080/10428194.2017.1289526. Epub 2017 Feb 20.

29.

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Tran HC, Wan Z, Sheard MA, Sun J, Jackson JR, Malvar J, Xu Y, Wang L, Sposto R, Kim ES, Asgharzadeh S, Seeger RC.

Clin Cancer Res. 2017 Feb 1;23(3):804-813. doi: 10.1158/1078-0432.CCR-16-1743. Epub 2016 Oct 10.

30.

Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response.

Tierney KE, Ji L, Dralla SS, Yoo E, Yessaian A, Pham HQ, Roman L, Sposto R, Mhawech-Fauceglia P, Lin YG.

Gynecol Oncol. 2016 Dec;143(3):650-654. doi: 10.1016/j.ygyno.2016.10.015. Epub 2016 Oct 19.

PMID:
27771165
31.

Value of routine staging imaging studies for patients with stage III breast cancer.

Piatek CI, Ji L, Kaur C, Russell CA, Tripathy D, Church T, Sposto R, Sener SF, Garcia AA.

J Surg Oncol. 2016 Dec;114(8):917-921. doi: 10.1002/jso.24436. Epub 2016 Sep 19.

PMID:
27642105
32.

Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.

Sun W, Orgel E, Malvar J, Sposto R, Wilkes JJ, Gardner R, Tolbert VP, Smith A, Hur M, Hoffman J, Rheingold SR, Burke MJ, Wayne AS.

Pediatr Blood Cancer. 2016 Nov;63(11):1943-8. doi: 10.1002/pbc.26129. Epub 2016 Jul 20.

PMID:
27437864
33.

Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.

Espinoza JC, Haley K, Patel N, Dhall G, Gardner S, Allen J, Torkildson J, Cornelius A, Rassekh R, Bedros A, Etzl M, Garvin J, Pradhan K, Corbett R, Sullivan M, McGowage G, Stein D, Jasty R, Sands SA, Ji L, Sposto R, Finlay JL.

Pediatr Blood Cancer. 2016 Oct;63(10):1806-13. doi: 10.1002/pbc.26118. Epub 2016 Jun 22.

34.

A parent-directed intervention for addressing academic risk in Latino survivors of childhood leukemia: results of a pilot study.

Bava L, Malvar J, Sposto R, Okada M, Gonzalez-Morkos B, Schweers LM, Nuñez C, Ruccione K, Katz ER, Freyer DR.

Psychooncology. 2016 Oct;25(10):1246-1249. doi: 10.1002/pon.4188. Epub 2016 Jul 4. No abstract available.

PMID:
27271226
35.

The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality.

Sposto R, Keegan TH, Vigen C, Kwan ML, Bernstein L, John EM, Cheng I, Yang J, Koo J, Kurian AW, Caan BJ, Lu Y, Monroe KR, Shariff-Marco S, Gomez SL, Wu AH.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1064-72. doi: 10.1158/1055-9965.EPI-15-1326. Epub 2016 Apr 26.

36.

Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.

Ater JL, Xia C, Mazewski CM, Booth TN, Freyer DR, Packer RJ, Sposto R, Vezina G, Pollack IF.

Cancer. 2016 Jun 15;122(12):1928-36. doi: 10.1002/cncr.29987. Epub 2016 Apr 8.

37.

Impact of a Rapid Blood Culture Assay for Gram-Positive Identification and Detection of Resistance Markers in a Pediatric Hospital.

Felsenstein S, Bender JM, Sposto R, Gentry M, Takemoto C, Bard JD.

Arch Pathol Lab Med. 2016 Mar;140(3):267-75. doi: 10.5858/arpa.2015-0119-OA.

PMID:
26927722
38.

A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.

Cooper TM, Cassar J, Eckroth E, Malvar J, Sposto R, Gaynon P, Chang BH, Gore L, August K, Pollard JA, DuBois SG, Silverman LB, Oesterheld J, Gammon G, Magoon D, Annesley C, Brown PA.

Clin Cancer Res. 2016 Aug 15;22(16):4014-22. doi: 10.1158/1078-0432.CCR-15-1998. Epub 2016 Feb 26.

39.

Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy.

Orgel E, Mueske NM, Sposto R, Gilsanz V, Freyer DR, Mittelman SD.

Leuk Lymphoma. 2018 Jan;59(1):138-145. doi: 10.3109/10428194.2015.1136741. Epub 2016 Jan 27.

40.

Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).

Vigen C, Kwan ML, John EM, Gomez SL, Keegan TH, Lu Y, Shariff-Marco S, Monroe KR, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Bernstein L, Sposto R, Wu AH.

Cancer Causes Control. 2016 Mar;27(3):391-401. doi: 10.1007/s10552-016-0715-8. Epub 2016 Jan 21.

41.

Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.

Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, Asgharzadeh S.

Neuro Oncol. 2016 Jan;18(1):126-31. doi: 10.1093/neuonc/nov097. Epub 2015 Aug 8.

42.

Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Meeske KA, Ji L, Freyer DR, Gaynon P, Ruccione K, Butturini A, Avramis VI, Siegel S, Matloub Y, Seibel NL, Sposto R.

Pediatr Blood Cancer. 2015 Dec;62(12):2140-9. doi: 10.1002/pbc.25628. Epub 2015 Jul 14.

43.

Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer.

Shariff-Marco S, Yang J, John EM, Kurian AW, Cheng I, Leung R, Koo J, Monroe KR, Henderson BE, Bernstein L, Lu Y, Kwan ML, Sposto R, Vigen CL, Wu AH, Keegan TH, Gomez SL.

J Community Health. 2015 Dec;40(6):1287-99. doi: 10.1007/s10900-015-0052-y.

44.

Contribution of the neighborhood environment and obesity to breast cancer survival: the California Breast Cancer Survivorship Consortium.

Cheng I, Shariff-Marco S, Koo J, Monroe KR, Yang J, John EM, Kurian AW, Kwan ML, Henderson BE, Bernstein L, Lu Y, Sposto R, Vigen C, Wu AH, Gomez SL, Keegan TH.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1282-90. doi: 10.1158/1055-9965.EPI-15-0055. Epub 2015 Jun 10.

45.

History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium.

Lu Y, John EM, Sullivan-Halley J, Vigen C, Gomez SL, Kwan ML, Caan BJ, Lee VS, Roh JM, Shariff-Marco S, Keegan TH, Kurian AW, Monroe KR, Cheng I, Sposto R, Wu AH, Bernstein L.

Am J Epidemiol. 2015 Jun 15;181(12):944-55. doi: 10.1093/aje/kwu466. Epub 2015 Apr 29.

46.

Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.

Sheard MA, Ghent MV, Cabral DJ, Lee JC, Khankaldyyan V, Ji L, Wu SQ, Kang MH, Sposto R, Asgharzadeh S, Reynolds CP.

Exp Cell Res. 2015 May 15;334(1):78-89. doi: 10.1016/j.yexcr.2015.03.024. Epub 2015 Apr 3.

PMID:
25845499
47.

Improving access to novel agents for childhood leukemia.

Sun W, Gaynon PS, Sposto R, Wayne AS.

Cancer. 2015 Jun 15;121(12):1927-36. doi: 10.1002/cncr.29267. Epub 2015 Feb 11. Review.

48.

Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis.

HaDuong JH, Blavier L, Baniwal SK, Frenkel B, Malvar J, Punj V, Sposto R, DeClerck YA.

Int J Cancer. 2015 Aug 15;137(4):797-809. doi: 10.1002/ijc.29465. Epub 2015 Feb 21.

49.

Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital.

Wu E, Rogers A, Ji L, Sposto R, Church T, Roman L, Tripathy D, Lin YG.

J Oncol Pract. 2015 Mar;11(2):e163-9. doi: 10.1200/JOP.2014.001529. Epub 2015 Jan 20.

50.

Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC).

Wu AH, Kurian AW, Kwan ML, John EM, Lu Y, Keegan TH, Gomez SL, Cheng I, Shariff-Marco S, Caan BJ, Lee VS, Sullivan-Halley J, Tseng CC, Bernstein L, Sposto R, Vigen C.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):361-8. doi: 10.1158/1055-9965.EPI-14-1140. Epub 2014 Nov 25.

Supplemental Content

Loading ...
Support Center